Skip to main content
. 2018 Apr 27;9(10):1863–1869. doi: 10.7150/jca.24950

Fig 1.

Fig 1

Treatment and follow-up process of patients. Abbreviations used: ALK: anaplastic lymphoma kinase; ROS1: c-ros oncogene 1; RECIST: Response Evaluation Criteria in Solid Tumors; PD: progressive disease; PR: partial response; SD: stable disease; bid: twice daily